[ad_1]
Kenvue Inc. Tylenol model ache reliever on the market at a pharmacy in New York, US, on Wednesday, March 27, 2024.
Bloomberg | Bloomberg | Getty Pictures
Shares of Kenvue fell greater than 10% on Friday after a report that Well being and Human Companies Secretary Robert F. Kennedy Jr. will doubtless hyperlink autism to the usage of the corporate’s ache treatment Tylenol in pregnant girls.
HHS will launch the report that might draw that hyperlink this month, the Wall Road Journal reported on Friday.
That report can even recommend a drugs derived from folate – a water-soluble vitamin – can be utilized to deal with signs of the developmental dysfunction in some folks, in line with the Journal.
In a press release, an HHS spokesperson stated “We’re utilizing gold-standard science to unravel America’s unprecedented rise in autism charges.”
“Till we launch the ultimate report, any claims about its contents are nothing greater than hypothesis,” they added.
Tylenol might be the newest extensively used and accepted remedy that Kennedy has undermined on the helm of HHS, which oversees federal well being companies that regulate medicine and different therapies. Kennedy has additionally taken steps to vary vaccine coverage within the U.S., and has amplified false claims about protected and efficient photographs that use mRNA expertise.
Kennedy has made the dysfunction a key focus of HHS, pledging in April that the company will “know what has induced the autism epidemic” by September and get rid of exposures. He additionally stated that month that the company has launched a “huge testing and analysis effort” involving lots of of scientists worldwide that may decide the trigger.
In a press release, Kenvue stated it has “repeatedly evaluated the science and [continues] to consider there isn’t a causal hyperlink” between the usage of acetaminophen, the generic identify for Tylenol, throughout being pregnant and autism.
The corporate added that the Meals and Drug Administration and main medical organizations “agree on the protection” of the drug, its use throughout being pregnant and the knowledge offered on the Tylenol label.
The FDA web site says the company has not discovered “clear proof” that applicable use of acetaminophen throughout being pregnant causes “hostile being pregnant, beginning, neurobehavioral, or developmental outcomes.” However the FDA stated it advises pregnant girls to talk with their health-care suppliers earlier than utilizing over-the-counter medicine.
The American Faculty of Obstetricians and Gynecologists maintains that acetaminophen is protected throughout being pregnant when taken as directed and after consulting a health-care supplier.
Some earlier research have prompt the drug poses dangers to fetal improvement, and some mother and father have introduced lawsuits claiming that they gave beginning to youngsters with autism after utilizing it.
However a federal choose in Manhattan dominated in 2023 that a few of these lawsuits lacked scientific proof and later ended the litigation in 2024. Some analysis has additionally discovered no affiliation between acetaminophen use and autism.
In a notice on Friday, BNP Paribas analyst Navann Ty stated the agency believes the “hurdle to proving causation [between the drug and autism] is excessive, significantly on condition that the litigation beforehand concluded in Kenvue’s favor.”
— CNBC’s Angelica Peebles contributed to this report.
[ad_2]
